Organogenesis (NSDQ:ORGO) posted second-quarter results this week that beat the overall consensus on Wall Street. The Canton, Mass.–based regenerative medicine company reported profits of $20.7 million, or 15¢ per share, on sales of $123.2 million for the three months ended June 30 for a sales growth of 78.65% compared with Q2 2020. Earnings per share were […]
Organogenesis Inc.
Organogenesis names new chief financial officer
Organogenesis this week said it appointed David Francisco as the company’s chief financial officer, effective Feb. 15. Francisco replaces Henry Hagopian, who will move on to become the company’s senior VP of finance and treasurer. “I am pleased to welcome Dave to the Organogenesis executive leadership team,” president and CEO Gary Gillheeney said in a […]
Organogenesis up 10% on Street-beating Q2 results
Organogenesis (NSDQ:ORGO) posted second-quarter results this week that beat the consensus on Wall Street. The Canton, Mass.-based company reported losses of $5.2 million, or -5¢ per share, on sales of $68.9 million for the three months ended June 30, for a bottom-line loss of -46.5% sales growth of 6.2% compared with Q2 2019. Earnings per share […]
Organogenesis boosts outlook on higher Q2 sales
Organogenesis (NSDQ:ORGO) beat The Street on sales for the second quarter of 2019 and boosted its outlook for the rest of the year amid continued strong sales growth in its wound-care business. The Canton, Mass.–based regenerative medicine company reported a loss of $9.65 million, or -11¢ per share, on sales of $64.95 million for the […]
Organogenesis boosts revenue, cuts losses in Q1
Organogenesis (NSDQ:ORGO) posted a smaller loss year-over-year during its first quarter, and boosted its outlook for the rest of the year amid strong sales growth in its wound-care business. The Canton, Mass.–based regenerative medicine company reported a loss of $15.7 million, or 17 cents per share, on sales of $57.1 million for the three months […]
Appeals court reverses Organogenesis win in gender bias, retaliation lawsuit
A U.S. federal appeals court this week reversed a win for Organogenesis in an employment discrimination and retaliation lawsuit from former employees, according to recently released court documents. The U.S Court of Appeals for the Ninth Circuit reversed and remanded the case filed by former employees Angela Gonzales, Linda Boyd and Brandee Colombo against Canton, […]
Shareholders approve Avista, Organogenesis tie up
Private equity firm Avista Healthcare Public Acquisition Corp. yesterday approved its merger with regenerative medicine company Organogenesis. The merger won approval yesterday at separate special meetings of shareholders for both companies, Canton, Mass.-based Organogenesis said. As part of the deal, Avista invested a total of $92 million in the combined company, Organogenesis said. Avista also […]
Avista to acquire Organogenesis
Avista Healthcare Public Acquisition group said last Friday it inked deal to acquire Organogenesis for an undisclosed amount. As part of the deal, Avista Capital Partners private equity firm will invest $92 million into the newly acquired company, which is slated to be listed on the Nasdaq under the ticker symbol “ORGO” following the closing […]
Organogenesis launches new sizing option for PuraPly wound care device
MIT-spinoff Organogenesis announced today that its PuraPly antimicrobial wound care device is now available in a 1.6-cm disc size. The Canton, Mass.-based company’s PuraPly AM product includes a broad-spectrum antibiotic, polyhexamethylene biguanide, embedded into a purified native collagen matrix. The device is cleared to treat an array of wound types, including pressure ulcers, surgical wounds, trauma wounds and […]
RTI Surgical taps director for CFO, fills out roster | Personnel Moves, Sept. 19, 2017
RTI Surgical (NSDQ:RTIX) said yesterday that it’s tapping a board member to be CFO and adding a pair of medical device veterans to its executive roster. Alachua, Fla.-based RTI said it named director Jonathon Singer as its finance & administration chief effective Oct. 2, replacing Robert Jordheim. Singer, who resigned his board seat to accept […]
Organogenesis closes $20m credit facility
Organogenesis said today it closed a $20 million financing facility with Eastward Capital Partners. “Eastward Capital Partners is committed to partnering with technology-forward companies who are leaders in their industry segments. We are excited to partner with Organogenesis to provide the capital to support their growth plans,” Eastward Partner’s Tim O’Loughlin said in a prepared statement. “We […]
